Total Liabilities (Quarterly) Chart

View Total Liabilities (Quarterly) for SANA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Liabilities (Quarterly) Chart
Start Trial

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 276.95M
March 31, 2026 254.35M
December 31, 2025 265.84M
September 30, 2025 240.12M
June 30, 2025 239.09M
March 31, 2025 236.39M
December 31, 2024 250.52M
September 30, 2024 266.91M
June 30, 2024 279.02M
March 31, 2024 306.24M
December 31, 2023 277.79M
September 30, 2023 265.59M
June 30, 2023 352.12M
March 31, 2023 318.67M
Date Value
December 31, 2022 323.40M
September 30, 2022 332.08M
June 30, 2022 331.58M
March 31, 2022 345.96M
December 31, 2021 400.90M
September 30, 2021 402.67M
June 30, 2021 353.94M
March 31, 2021 422.48M
December 31, 2020 298.58M
September 30, 2020
June 30, 2020
March 31, 2020
December 31, 2019 140.88M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
Twist Bioscience Corp. 226.70M
Beam Therapeutics, Inc. 318.91M
Prime Medicine, Inc. 209.23M
Intellia Therapeutics, Inc. 129.46M
Moderna, Inc. 4.20B

Total Liabilities (Quarterly) Related Metrics